New USC clinical trial for asthma sufferers - University of the Sunshine Coast, Queensland, Australia

Accessibility links

USC News

New USC clinical trial for asthma sufferers

1 May 2017

The University of the Sunshine Coast’s Clinical Trials Centre is about to start testing the effectiveness and safety of a potential new triple therapy medicine to better manage and treat asthma.

The centre, which last year started trialling different treatments for epilepsy, emphysema and influenza, is now accepting volunteer participants for the asthma research.

Centre director Lucas Litewka said volunteers were needed to test the new medicine, which combined corticosteroids that helped reduce inflammation and bronchodilators that helped open up and relax the muscles in the airways of the lungs.

“Asthma is a long-term lung condition that cannot be cured, but for most people it can be controlled with a daily management plan,” Mr Litewka said.

The USC centre has partnered with Golden Beach Medical Centre on the medical research.

General practitioner Dr Peter de Wet is the principal investigator on this USC clinical trial.

Dr de Wet said the once-a-day treatment might reduce the need for patients to carry around multiple puffers and undergo complicated treatment regimes.

Asthmatics who continue to experience asthma flare-ups despite taking current treatment can contact the trial centre.

Clinical trials are medical research studies aimed at finding new or better ways to treat and manage health conditions and illnesses. The USC Centre started operating in 2016.

For details go to or

— Julie Schomberg

USC Clinical Trials Centre's Georgina Street and Golden Beach Medical Centre's Dr Peter De Wet

Related articles

Study to assess patient confidence in clinical trials
9 Jan

USC Clinical Trials will this year develop a new way to evaluate and improve the experience of medical trial participants, thanks to a new grant.

Clinical trial of medication that targets triglycerides
1 Dec 2019

USC Clinical Trials will participate in a study of an investigational medication for the treatment of dyslipidaemia – a condition that involves abnormally elevated levels of lipids (fats) in the blood.

ARC CEO Dr Shanny Dyer presents award to Lucas Litewka
Clinical trials commitment earns industry award
4 Nov 2019

The Director of USC Clinical Trials, Lucas Litewka, has been recognised nationally for his significant contribution to the medical technology and pharmaceuticals (MTP) sector.

Contact the USC media team

Name Position Email Phone
Terry Walsh Manager, Media and Messaging +61 7 5430 1160
Janelle Kirkland Media Relations Coordinator +61 7 5459 4553
Clare McKay Media Relations Officer (Regional) +61 7 5456 5669

Search results for

Recent news